Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 12, Issue 2, Pages 117-122

Elevated Plasma Level of Leukotrienes in Bronchial Asthma Patients: A Possible Clinical Relevance

Mahmoud Mansour,1 Nabil Farouk,1 Abbas El Maragy,2 Ibrahim Radwan,1 and Omar El-Ahmady1

1Tumor Marker Oncology Research Center, Al-Azhar University, Cairo, Egypt
2Chest Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Received 22 December 1994

Copyright © 1994 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Plasma from bronchial asthma patients and healthy controls was investigated for the content of lipoxygenase products. After lipid extraction using SEP-PAK C18 Cartridges, the lipoxygenase products were measured by Enzyme-Immunoassay. Elevated chemotactic B4 was found in plasma from asthmatic patients with mean value (483±75) pmoUL, while the mean value in normal healthy donors was (140± 12.1) pmol/L (M±SE). The levels of spasmogenic cysteinyl containing leukotrienes were also very high in the bronchial asthma patients. Elevations of leukotriene B4 and cysteinyl containing leukotrienes were detected during attacks of bronchial asthma. These results suggest that leukotriene B4 may be important in the pathogenesis of bronchial asthma and confirmed that peptidoleukotrienes playa role as chemical mediators during the asthmatic attack.